We have temporarily paused our Prompt Prostate Genetic Score™ (PGS) test and we are not accepting orders at this time. We expect the product will remain paused until at least December 31, 2022. Contact clientservices@invitae.com if you have questions.

Helping men stay healthy is at the core of what we do.

Our simple telehealth process meets the current needs of both patients and health care providers.

How Common is Prostate Cancer - Am I at Risk?

When detected early, Prostate Cancer survival rate is greater than 98%

How Do I Detect Prostate Cancer Early?

Get Started

What’s in Your Genes?

Is Prostate Cancer Screening Right for Me?

Get the Test

What is Your Personalized Risk for Prostate Cancer?

Prostate Cancer remains the 2nd most leading cause of cancer-related deaths in men, despite being curable with early detection.3 Due to controversial recommendations about the common screening tool, called PSA screening, early detection rates and prostate cancer screenings are declining. At the same time, the number of men with an incurable disease is on the rise.4

Regular screening has been recommended if you are at high risk – but how do you know your individual risk? Relying on family history alone may not be enough.

Prompt Prostate Genetic Score™(PGS) can help identify if you are at high risk.

Prompt the Conversation Today.

Using a simple cheek swab, Prompt PGS is able to identify those men at the highest risk of prostate cancer and empower them and their provider to take action by getting screened before it’s too late.

Get the test

What People Are Saying

Get My Personalized Score Today
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018: CA: a cancer journal for clinicians. 2018;98(1):7-30
  2. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30003374 World J Urol. 2018 Jul 12. doi: 10.1007/s00345-018-2407-3.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018: CA: a cancer journal for clinicians. 2018;98(1):7-30
  4. Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2018;124(13):2801-14. 4. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening.
  5. American Academy of Family Physicians. Prostate cancer: clinical preventive service recommendation. 2012 (http://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html)
  6. Ahlering T, et al. Unintended consequences of decreased PSA-based prostate cancer screening. https://www.ncbi.nlm.nih.gov/pubmed/30003374 World J Urol. 2018 Jul 12. doi: 10.1007/s00345-018-2407-3.
  7. In the Prostate Cancer Prevention Trial (PCPT trial), family history and annual PSA would have detected 26% of high grade cancers, while Prompt PGS would have detected 84% of high grade cancers.
  8. In the PCPT trial, annual PSA would have led to 11,262 screening events to detect 64% of all high grade cancers, while Prompt PGS would have led to 4,810 screening events to detect 84% of all high grade cancer
×